{
    "organizations": [],
    "uuid": "a54ac4c4486969c3dfb4e762230b91731f136a99",
    "author": "",
    "url": "https://www.reuters.com/article/brief-applied-genetic-technologies-repor/brief-applied-genetic-technologies-reports-qtrly-loss-per-share-of-0-29-idUSASB0C50R",
    "ord_in_thread": 0,
    "title": "BRIEF-Applied Genetic Technologies Reports Qtrly Loss Per Share Of ‍$0.29​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 07 PM / a few seconds ago BRIEF-Applied Genetic Technologies Reports Qtrly Loss Per Share Of ‍$0.29​ Reuters Staff \nFeb 9 (Reuters) - Applied Genetic Technologies Corp : * QUARTERLY REVENUE $4.9 MILLION VERSUS $22.7 MILLION * QTRLY LOSS PER SHARE ‍$ 0.29​ \n* ‍AS OF DECEMBER 31, 2017, COMPANY‘S CASH, CASH EQUIVALENTS, AND INVESTMENTS AMOUNTED TO $119.7 MILLION​ \n* ‍EXPECTS TOTAL CASH, CASH EQUIVALENTS, AND INVESTMENTS AS OF JUNE 30, 2018 TO BE BETWEEN $90 AND $100 MILLION​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-09T14:06:00.000+02:00",
    "crawled": "2018-02-09T14:21:41.057+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "second",
        "ago",
        "genetic",
        "technology",
        "report",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "applied",
        "genetic",
        "technology",
        "corp",
        "quarterly",
        "revenue",
        "million",
        "versus",
        "million",
        "qtrly",
        "loss",
        "per",
        "share",
        "december",
        "company",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "amounted",
        "total",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "june",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}